CME/CE
Your professional development is critical to the care of your patients. Stay on top of the latest treatments and information with ReachMD's CME activities. Our topics span cardiology, diabetes, oncology, women's health and more. And our CME library is continuously growing, every quarter.
Episodes 166-180 of 745
Molecular Magic: Decoding the Unique Mechanism of CELMoDs
MinuteCE®Molecular Magic: Decoding the Unique Mechanism of CELMoDs
Precision Targeting: Matching CELMoDs to the Right Patient With Myeloma
MinuteCE®Precision Targeting: Matching CELMoDs to the Right Patient With Myeloma
Mastering the Sequence: CELMoDs Across Treatment Lines
MinuteCE®Mastering the Sequence: CELMoDs Across Treatment Lines
Safety First: Navigating CELMoD-Associated Toxicities
MinuteCE®Safety First: Navigating CELMoD-Associated Toxicities
- advertisement
Real-World Ready: Practical Tips for Community Oncologists
MinuteCE®Real-World Ready: Practical Tips for Community Oncologists
Case Application: Frontline Insights—Tackling Newly Diagnosed Myeloma
MinuteCE®Case Application: Frontline Insights—Tackling Newly Diagnosed Myeloma
Case Application: Unlocking Relapsed/Refractory Myeloma With CELMoDs
MinuteCE®Case Application: Unlocking Relapsed/Refractory Myeloma With CELMoDs
Next-Generation Innovations: The Future of CELMoDs in Myeloma
MinuteCE®Next-Generation Innovations: The Future of CELMoDs in Myeloma
Chairperson Perspective: Acromegaly Care: Individualized Diagnosis and Management Strategies
CME/CEChairperson Perspective: Acromegaly Care: Individualized Diagnosis and Management Strategies
Latest Data Publication on Quantifying the Link Between TTR Response and Mortality Reduction
CME/CELatest Data Publication on Quantifying the Link Between TTR Response and Mortality Reduction
- advertisement
Advanced Therapeutic Strategies and Resistance Mechanisms in CLL
CME/CEAdvanced Therapeutic Strategies and Resistance Mechanisms in CLL
Breaking New Ground: Acoramidis Reduces AF Events in ATTR CM Patients from ESC Heart Failure 2025
CME/CEBreaking New Ground: Acoramidis Reduces AF Events in ATTR CM Patients from ESC Heart Failure 2025
Continuity in Care: Strategies for Managing Growth Hormone Deficiency Through Life’s Stages
CME/CEContinuity in Care: Strategies for Managing Growth Hormone Deficiency Through Life’s Stages
